Is FUM or SNG more profitable?

Synairgen has a net margin of 0.00% compared to Futura Medical's net margin of -534.62%. Synairgen's return on equity of -51.06% beat Futura Medical's return on equity. Company Net Margins Return on Equity Return on Assets Futura Medical -534.62% -310.00% -26.59% Synairgen N/A -51.06% -30.58%

Does the media favor FUM or CIZ?

In the previous week, Futura Medical and Futura Medical both had 1 articles in the media. Cizzle Biotechnology's average media sentiment score of 0.88 beat Futura Medical's score of 0.75 indicating that Cizzle Biotechnology is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Futura Medical 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cizzle Biotechnology 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Futura Medical (FUM) Competitors

GBX 0.34 -0.01 (-2.82%)

As of 07/21/2026 11:54 AM Eastern

Compare

FUM vs. SNG, BVX, CIZ, OPTI, and OBD

Should you buy Futura Medical stock or one of its competitors? MarketBeat compares Futura Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Futura Medical include Synairgen (SNG), BiVictriX Therapeutics (BVX), Cizzle Biotechnology (CIZ), OptiBiotix Health (OPTI), and Oxford BioDynamics (OBD). These companies are all part of the "biotechnology" industry.

How does Futura Medical compare to Synairgen?

Futura Medical (LON:FUM) and Synairgen (LON:SNG) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, valuation, media sentiment, analyst recommendations, dividends, earnings, institutional ownership and profitability.

Futura Medical has a beta of 0.021, meaning that its stock price is 98% less volatile than the broader market. Comparatively, Synairgen has a beta of -2.23, meaning that its stock price is 323% less volatile than the broader market.

Futura Medical has higher revenue and earnings than Synairgen. Futura Medical is trading at a lower price-to-earnings ratio than Synairgen, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Futura Medical	£1.70M	1.18	-£3.88M	-£2.78	N/A
Synairgen	N/A	N/A	-£15.86M	-£1.66	N/A

1.0% of Futura Medical shares are owned by institutional investors. Comparatively, 30.7% of Synairgen shares are owned by institutional investors. 16.0% of Futura Medical shares are owned by company insiders. Comparatively, 3.2% of Synairgen shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Futura Medical had 1 more articles in the media than Synairgen. MarketBeat recorded 1 mentions for Futura Medical and 0 mentions for Synairgen. Futura Medical's average media sentiment score of 0.75 beat Synairgen's score of 0.00 indicating that Futura Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Futura Medical	Positive
Synairgen	Neutral

Synairgen has a net margin of 0.00% compared to Futura Medical's net margin of -534.62%. Synairgen's return on equity of -51.06% beat Futura Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Futura Medical	-534.62%	-310.00%	-26.59%
Synairgen	N/A	-51.06%	-30.58%

Summary

Futura Medical beats Synairgen on 8 of the 12 factors compared between the two stocks.

How does Futura Medical compare to BiVictriX Therapeutics?

BiVictriX Therapeutics (LON:BVX) and Futura Medical (LON:FUM) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, media sentiment, analyst recommendations, risk, institutional ownership, profitability and earnings.

BiVictriX Therapeutics has higher earnings, but lower revenue than Futura Medical. Futura Medical is trading at a lower price-to-earnings ratio than BiVictriX Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BiVictriX Therapeutics	N/A	N/A	-£2.67M	-£0.04	N/A
Futura Medical	£1.70M	1.18	-£3.88M	-£2.78	N/A

BiVictriX Therapeutics has a net margin of 0.00% compared to Futura Medical's net margin of -534.62%. BiVictriX Therapeutics' return on equity of -103.99% beat Futura Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BiVictriX Therapeutics	N/A	-103.99%	-62.99%
Futura Medical	-534.62%	-310.00%	-26.59%

BiVictriX Therapeutics has a beta of -0.73, suggesting that its stock price is 173% less volatile than the broader market. Comparatively, Futura Medical has a beta of 0.021, suggesting that its stock price is 98% less volatile than the broader market.

30.8% of BiVictriX Therapeutics shares are owned by institutional investors. Comparatively, 1.0% of Futura Medical shares are owned by institutional investors. 42.6% of BiVictriX Therapeutics shares are owned by insiders. Comparatively, 16.0% of Futura Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, Futura Medical had 1 more articles in the media than BiVictriX Therapeutics. MarketBeat recorded 1 mentions for Futura Medical and 0 mentions for BiVictriX Therapeutics. Futura Medical's average media sentiment score of 0.75 beat BiVictriX Therapeutics' score of 0.00 indicating that Futura Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
BiVictriX Therapeutics	Neutral
Futura Medical	Positive

Summary

BiVictriX Therapeutics and Futura Medical tied by winning 6 of the 12 factors compared between the two stocks.

How does Futura Medical compare to Cizzle Biotechnology?

Futura Medical (LON:FUM) and Cizzle Biotechnology (LON:CIZ) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, media sentiment, dividends, profitability, valuation and earnings.

Cizzle Biotechnology has a net margin of 0.00% compared to Futura Medical's net margin of -534.62%. Cizzle Biotechnology's return on equity of 104.99% beat Futura Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Futura Medical	-534.62%	-310.00%	-26.59%
Cizzle Biotechnology	N/A	104.99%	-31.72%

1.0% of Futura Medical shares are owned by institutional investors. Comparatively, 0.0% of Cizzle Biotechnology shares are owned by institutional investors. 16.0% of Futura Medical shares are owned by company insiders. Comparatively, 65.9% of Cizzle Biotechnology shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Cizzle Biotechnology has lower revenue, but higher earnings than Futura Medical. Cizzle Biotechnology is trading at a lower price-to-earnings ratio than Futura Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Futura Medical	£1.70M	1.18	-£3.88M	-£2.78	N/A
Cizzle Biotechnology	N/A	N/A	-£2.81K	-£0.17	N/A

In the previous week, Futura Medical and Futura Medical both had 1 articles in the media. Cizzle Biotechnology's average media sentiment score of 0.88 beat Futura Medical's score of 0.75 indicating that Cizzle Biotechnology is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Futura Medical	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cizzle Biotechnology	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Futura Medical has a beta of 0.021, indicating that its stock price is 98% less volatile than the broader market. Comparatively, Cizzle Biotechnology has a beta of 0.022, indicating that its stock price is 98% less volatile than the broader market.

Summary

Cizzle Biotechnology beats Futura Medical on 7 of the 11 factors compared between the two stocks.

How does Futura Medical compare to OptiBiotix Health?

OptiBiotix Health (LON:OPTI) and Futura Medical (LON:FUM) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, risk, media sentiment, analyst recommendations, earnings, valuation, dividends and institutional ownership.

OptiBiotix Health has a net margin of -333.62% compared to Futura Medical's net margin of -534.62%. OptiBiotix Health's return on equity of -52.92% beat Futura Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OptiBiotix Health	-333.62%	-52.92%	-13.93%
Futura Medical	-534.62%	-310.00%	-26.59%

In the previous week, Futura Medical had 1 more articles in the media than OptiBiotix Health. MarketBeat recorded 1 mentions for Futura Medical and 0 mentions for OptiBiotix Health. Futura Medical's average media sentiment score of 0.75 beat OptiBiotix Health's score of 0.00 indicating that Futura Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
OptiBiotix Health	Neutral
Futura Medical	Positive

0.4% of OptiBiotix Health shares are owned by institutional investors. Comparatively, 1.0% of Futura Medical shares are owned by institutional investors. 26.8% of OptiBiotix Health shares are owned by company insiders. Comparatively, 16.0% of Futura Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

OptiBiotix Health has a beta of 1.849, suggesting that its share price is 85% more volatile than the broader market. Comparatively, Futura Medical has a beta of 0.021, suggesting that its share price is 98% less volatile than the broader market.

OptiBiotix Health has higher earnings, but lower revenue than Futura Medical. OptiBiotix Health is trading at a lower price-to-earnings ratio than Futura Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OptiBiotix Health	£1.17M	4.88	-£3.09M	-£3.84	N/A
Futura Medical	£1.70M	1.18	-£3.88M	-£2.78	N/A

Summary

OptiBiotix Health beats Futura Medical on 7 of the 13 factors compared between the two stocks.

How does Futura Medical compare to Oxford BioDynamics?

Oxford BioDynamics (LON:OBD) and Futura Medical (LON:FUM) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, risk, dividends, earnings, analyst recommendations, institutional ownership and media sentiment.

Oxford BioDynamics has a beta of 0.42, indicating that its stock price is 58% less volatile than the broader market. Comparatively, Futura Medical has a beta of 0.021, indicating that its stock price is 98% less volatile than the broader market.

Futura Medical has higher revenue and earnings than Oxford BioDynamics. Oxford BioDynamics is trading at a lower price-to-earnings ratio than Futura Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Oxford BioDynamics	£1.20M	4.31	-£103.52M	-£0.20	N/A
Futura Medical	£1.70M	1.18	-£3.88M	-£2.78	N/A

Futura Medical has a net margin of -534.62% compared to Oxford BioDynamics' net margin of -825.61%. Futura Medical's return on equity of -310.00% beat Oxford BioDynamics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Oxford BioDynamics	-825.61%	-451.74%	-56.23%
Futura Medical	-534.62%	-310.00%	-26.59%

25.3% of Oxford BioDynamics shares are owned by institutional investors. Comparatively, 1.0% of Futura Medical shares are owned by institutional investors. 15.6% of Oxford BioDynamics shares are owned by insiders. Comparatively, 16.0% of Futura Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Futura Medical had 1 more articles in the media than Oxford BioDynamics. MarketBeat recorded 1 mentions for Futura Medical and 0 mentions for Oxford BioDynamics. Futura Medical's average media sentiment score of 0.75 beat Oxford BioDynamics' score of 0.00 indicating that Futura Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Oxford BioDynamics	Neutral
Futura Medical	Positive

Summary

Futura Medical beats Oxford BioDynamics on 9 of the 13 factors compared between the two stocks.

Get Futura Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FUM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

FUM vs. The Competition

Export

Metric	Futura Medical	Biotechnology Industry	Medical Sector	LON Exchange
Market Cap	£2.01M	£444.73M	£6.81B	£2.79B
Dividend Yield	4.55%	3.90%	2.67%	6.16%
P/E Ratio	-0.12	3.49	26.97	368.25
Price / Sales	1.18	6,249.84	507.39	84,392.87
Price / Cash	20.43	13.13	49.71	27.89
Price / Book	0.13	87.68	10.67	7.59
Net Income	-£3.88M	-£96.07M	£3.60B	£5.89B
7 Day Performance	-4.17%	-0.27%	-0.99%	0.16%
1 Month Performance	-46.09%	0.35%	1.60%	-0.87%
1 Year Performance	-97.27%	57.77%	24.14%	62.65%

Futura Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
FUM Futura Medical	N/A	GBX 0.35 -2.8%	N/A	-97.1%	£2.01M	£1.70M	N/A	12	Gap Up
SNG Synairgen	N/A	N/A	N/A	N/A	£9.04M	N/A	N/A	34	Gap Down
BVX BiVictriX Therapeutics	N/A	N/A	N/A	N/A	£8.25M	N/A	N/A	17	Gap Up High Trading Volume
CIZ Cizzle Biotechnology	N/A	GBX 1.85 -6.3%	N/A	+24.0%	£7.86M	N/A	N/A	4
OPTI OptiBiotix Health	N/A	GBX 5.59 -4.5%	N/A	-50.2%	£5.77M	£1.17M	N/A	1

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:FUM) was last updated on 7/22/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Futura Medical (FUM) Competitors

FUM vs. SNG, BVX, CIZ, OPTI, and OBD

How does Futura Medical compare to Synairgen?

Summary

How does Futura Medical compare to BiVictriX Therapeutics?

Summary

How does Futura Medical compare to Cizzle Biotechnology?

Summary

How does Futura Medical compare to OptiBiotix Health?

Summary

How does Futura Medical compare to Oxford BioDynamics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

FUM vs. The Competition

Futura Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Futura Medical (FUM) Competitors

FUM vs. SNG, BVX, CIZ, OPTI, and OBD

How does Futura Medical compare to Synairgen?

Which has more risk & volatility, FUM or SNG?

Which has better earnings & valuation, FUM or SNG?

Do insiders & institutionals have more ownership in FUM or SNG?

Does the media favor FUM or SNG?

Is FUM or SNG more profitable?

Summary

How does Futura Medical compare to BiVictriX Therapeutics?

Which has higher earnings & valuation, BVX or FUM?

Is BVX or FUM more profitable?

Which has more volatility & risk, BVX or FUM?

Do insiders and institutionals have more ownership in BVX or FUM?

Does the media prefer BVX or FUM?

Summary

How does Futura Medical compare to Cizzle Biotechnology?

Is FUM or CIZ more profitable?

Do insiders & institutionals hold more shares of FUM or CIZ?

Which has better earnings & valuation, FUM or CIZ?

Does the media favor FUM or CIZ?

Which has more risk and volatility, FUM or CIZ?

Summary

How does Futura Medical compare to OptiBiotix Health?

Is OPTI or FUM more profitable?

Does the media prefer OPTI or FUM?

Do institutionals and insiders have more ownership in OPTI or FUM?

Which has more risk and volatility, OPTI or FUM?

Which has stronger valuation & earnings, OPTI or FUM?

Summary

How does Futura Medical compare to Oxford BioDynamics?

Which has more volatility and risk, OBD or FUM?

Which has better earnings and valuation, OBD or FUM?

Is OBD or FUM more profitable?

Do institutionals & insiders believe in OBD or FUM?

Does the media prefer OBD or FUM?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

FUM vs. The Competition

Futura Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools